GlassScriptPhysician profile
David W Noller
NPI 1922156157
$7,172.81
in general payments reported to CMS, 2019-2025
40 companies · $1,713 in 2025
The $1,713 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,112 · 2020: $503 · 2021: $585 · 2022: $1,312 · 2023: $988 · 2024: $960 · 2025: $1,713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,655 · Education: $4.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,655.32 |
| Education | $4.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,835.21 | 2019-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $1,488.41 | 2023-2025 | Gemtesa, Orgovyx |
| Amgen INC. | $474.28 | 2019-2023 | Xgeva |
| Dendreon Pharmaceuticals LLC | $353.42 | 2019-2024 | Provenge |
| Urovant Sciences INC | $274.50 | 2022 | |
| Abbvie INC. | $249.16 | 2019-2025 | |
| Janssen Biotech, INC. | $248.35 | 2019-2025 | Erleada, Akeega, Balversa |
| Antares Pharma, INC. | $183.79 | 2019-2024 | Xyosted, Nocdurna, Tlando |
| Accord Healthcare, INC. | $176.74 | 2022-2025 | |
| 180 Medical, INC. | $174.71 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $155.18 | 2020-2025 | Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $137.72 | 2019-2025 | |
| Progenics Pharmaceuticals, INC. | $131.32 | 2022-2025 | Pylarify |
| Ferring Pharmaceuticals INC. | $116.05 | 2025 | Adstiladrin |
| Coloplast Corp | $108.44 | 2019-2020 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Noller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.